CAPA In-vitro Oocyte Maturation (CUHK Medical Centre Limited)
Not Applicable
Not yet recruiting
- Conditions
- Infertility, Female
- Registration Number
- NCT07083427
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
In vitro oocyte maturation (IVM) is a mild-approach assisted reproductive technology (ART). Because of its simplicity, the more favorable financial implications (reduced cost) for patients, and the lower health risk profile of IVM compared to controlled ovarian stimulation (COS) in polycystic ovary syndrome (PCOS) patients, the use of IVM in selected patients may gain increasing interest. Besides its application in patients with polycystic ovaries, IVM technology may have a role in fertility preservation, where young girls and adult women are facing infertility due to gonadotoxic chemotherapeutic treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
- Patients aged from 18-50 years old
- Patients seek fertility preservation services
- Patients seek oocyte retrieval services
Exclusion Criteria
- Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number of mature oocytes 1 week Number of mature oocytes after IVM
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Prince of Wales Hospital
🇭🇰Hong Kong, Hong Kong
Prince of Wales Hospital🇭🇰Hong Kong, Hong Kong